No Data Yet
The global drug delivery devices market is projected to reach US$450.7 billion by 2035, spurred by surging revenues from biologic drugs that are fueling multi-billion dollar investments in manufacturing capacity from pharmaceutical leaders.
A new report projects the global blood collection tubes market will reach $7.23 billion by 2032, driven by personalized medicine. However, this optimistic forecast is set against a backdrop of significant regulatory uncertainty at the U.S. Food and Drug Administration (FDA), creating a complex risk environment for key industry players like Becton Dickinson, Bio-Rad, and Thermo Fisher Scientific.